In Uterine Manipulators segmentation by Application, the market is bifurcated into Hysterectomy and Uterine Surgery. Hysterectomy, representing approximately 65% of the market, dominates due to its prevalence in gynecological procedures for uterine removal. This segment is driven by rising incidence of uterine fibroids, endometriosis, and cancer. Uterine Surgery, accounting for 35%, includes procedures like myomectomy and endometrial ablation, which rely on manipulators for tissue access and instrument guidance. The segmentation underscores how procedural demand directly correlates with market size, with hysterectomy’s higher frequency and complexity sustaining larger revenue shares. Analytical insights indicate that advancements in minimally invasive techniques, particularly robotic-assisted platforms, will further solidify the dominance of the hysterectomy segment.